Annual Drug Patent Expirations for JAKAFI
Jakafi is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug and one Paragraph IV challenge.
This drug has one hundred and forty-nine patent family members in forty-one countries.
Copyright © DrugPatentWatch. Originally published at Patent delisted for Incyte Corp drug JAKAFI